Invitris Phagen-Therapie: Wie Patrick Grossmann Medikamente in 8 Stunden druckt

Invitris' phage therapy, a DeepTech startup, revolutionizes medicine by producing new drugs in 4 to 8 hours using a cell-free platform. Founder Dr. Patrick Grossmann calls this the "ChatGPT moment" for pharma, with AI radically transforming personalized therapies.